SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (751)11/25/2001 3:06:36 AM
From: dalroi  Respond to of 2243
 
Concerning PTIE
FWIW
there are already "similar principal" products on the market like Valtran drops and in europe they were never a big succes.
Further more they now have listed 5 products from which one finished its fase 2 in 1999 and apears to be on hold why ?
I poled some of our anaesthesiologists and they wer very sceptical.

So while i held some of the stock , i sold it in a rally because of reason 3

cheers

Stefaan who hopes to be wrong on this one :-)



To: Spekulatius who wrote (751)11/26/2001 3:40:44 PM
From: Biomaven  Read Replies (1) | Respond to of 2243
 
<PTIE>

I owned a little at one point on not that much DD. There seems to be enough skepticism about the drug mechanism that I decided to exit but keep an eye on it. I was also concerned about possible different effects in men and women, which would certainly complicate development.

I still own a little POZN though if you want to persist in rummaging in the lockup locker. <g>

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News